Xingxing Zang, Ph.D.

Microbiology & Immunology

Phone718-430-4155
Emailxingxing.zang@einsteinmed.org
Websitehttp://www.einstein.yu.edu/faculty/11141/xingxing-zang/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Xingxing Zang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3 Finished

Mechanisms and therapies of B7x and B7-H3 in T1D
Zang, X.
9/25/15 → 8/31/20
Project: Research project
The B7x pathway in the tumor microenvironment
Zang, X.
4/1/14 → 3/31/20
Project: Research project
New T Cell Coinhibitory Pathway and Type 1 Diabetes
Zang, X.
9/30/08 → 8/31/13
Project: Research project

4623 Citations
33 h-Index
54 Article
20 Review article
4 Comment/debate
1 Chapter

LAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin lymphoma
Moerdler, S., Ewart, M., Friedman, D. L., Kelly, K., Pei, Q., Peng, M., Zang, X. X. & Cole, P. D., 2021, In: Leukemia and Lymphoma. 62, 3, p. 606-613 8 p.
Research output: Contribution to journal › Article › peer-review
PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies
Nishimura, C. D., Pulanco, M. C., Cui, W., Lu, L. & Zang, X., Mar 2021, In: Trends in Molecular Medicine. 27, 3, p. 207-219 13 p.
Research output: Contribution to journal › Review article › peer-review
Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer
Li, Y., Liu, Y., Zhao, N., Yang, X., Li, Y., Zhai, F., Zang, X. & Cui, W., Sep 1 2020, In: Cell Death and Disease. 11, 9, 753.
Research output: Contribution to journal › Article › peer-review

Open Access
Correction to: Downregulation of nicotinamide N-methyltransferase inhibits migration and epithelial-mesenchymal transition of esophageal squamous cell carcinoma via Wnt/β-catenin pathway (Molecular and Cellular Biochemistry, (2019), 460, 1-2, (93-103), 10.1007/s11010-019-03573-0)
Cui, Y., Zhang, L., Wang, W., Ma, S., Liu, H., Zang, X., Zhang, Y. & Guan, F., Sep 1 2020, In: Molecular and Cellular Biochemistry. 472, 1-2, p. 263-264 2 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis
Boor, P. P. C., Sideras, K., Biermann, K., Hosein Aziz, M., Levink, I. J. M., Mancham, S., Erler, N. S., Tang, X., van Eijck, C. H., Bruno, M. J., Sprengers, D., Zang, X. & Kwekkeboom, J., Apr 14 2020, In: British Journal of Cancer. 122, 8, p. 1211-1218 8 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations